Allarity Therapeutics, Inc.
ALLR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001860657
No open-market purchases or sales by Allarity Therapeutics, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Allarity Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 10 | 10 | 0 |
| Shares | 165.3K | 145.1K | −20.2K (−12.2%) |
| Value | $181.0K | $42.0K | −$139.0K (−76.8%) |
New holders (2)
Institutions that held Allarity Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 12,534 | $3.68K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,936 | $1.00K | 0.00% |
Sold out (2)
Institutions that held Allarity Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| LMR Partners LLP | 46,033 | $51.0K |
| Barclays PLC | 16,147 | $18.0K |